ENTPD1 and B-cell chronic lymphocytic leukemia: However, when CLL patients were divided into two subgroups, stages 0–2 and stages 3–4, it was found that the earlier stage CLL patients had higher CD39 activity than normal B-lymphocytes, whereas later stage CLL patients had lower CD39 activity than normal B-lymphocytes.